Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life.

Sarah Deschuymer D Nevens Fréderic Duprez J F Daisne M Voordeckers Wilfried De Neve Sandra Nuyts

Published in: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation (2020)

QoL during RT for head and neck cancer tends to be less impaired in the 40 Gy arm. However, reducing the dose only on the elective neck does not result in clinically relevant improvement of QoL. Therefore, additional treatment strategies must be examined to further improve the QoL of HNSCC patients.

Keyphrases

end stage renal disease
patients undergoing
newly diagnosed
ejection fraction
chronic kidney disease
early stage
prognostic factors
peritoneal dialysis
squamous cell carcinoma
locally advanced
radiation induced
rectal cancer